Sterenn Davis
About Sterenn Davis
Sterenn Davis is a Senior Principal Scientist at Adaptimmune, where she has worked since 2022. She has held various roles in the field of science, including positions at Theolytics, Immunocore, and UCL Institute of Ophthalmology, and she holds a PhD in Molecular Biophysics from the University of Exeter.
Current Role at Adaptimmune
Sterenn Davis serves as a Senior Principal Scientist at Adaptimmune, a position she has held since 2022. In this role, she focuses on advancing scientific research and development within the organization. Her expertise contributes to the development of innovative therapies aimed at treating cancer through T-cell receptor engineering.
Previous Experience at Theolytics
Prior to her current role, Sterenn Davis worked at Theolytics as a Team Leader from 2020 to 2022. During her two years at Theolytics, she led a team focused on the development of oncolytic virus therapies, contributing to the company's mission of advancing cancer treatment options.
Career at Immunocore
Sterenn Davis has significant experience from her time at Immunocore, where she worked for a total of six years in various roles. She served as a Senior Scientist from 2014 to 2019, followed by a year as Principal Scientist from 2019 to 2020. Her work at Immunocore involved research and development in the field of T-cell therapy, contributing to advancements in immuno-oncology.
Research Background at UCL Institute of Ophthalmology
Sterenn Davis began her research career as a Research Technician at the UCL Institute of Ophthalmology from 2011 to 2013. In this role, she supported various research projects focused on eye diseases and vision science, gaining valuable laboratory experience that laid the foundation for her future roles in scientific research.
Educational Qualifications from University of Exeter
Sterenn Davis holds a Master of Physics (MPhys) degree in Physics, which she earned from the University of Exeter from 2002 to 2006. She further pursued her academic career at the same institution, obtaining a Doctor of Philosophy (PhD) in Molecular Biophysics from 2006 to 2011. Her educational background provides a strong foundation for her work in scientific research and development.